The American Journal of Geriatric Psychiatry

Psychiatric diagnoses did not independently predict survival

A retrospective cohort study of 1,269 people with Alzheimer disease found neither psychiatric diagnoses nor recorded psychiatric drug exposure independently predicted survival over a median 112 months.

Paper by Chiao-Hsin Yen, Hsue-Wei Chan, Yu-Wen Chiu, Yung-Chieh Yen
Graphical abstract from The American Journal of Geriatric Psychiatry
Open the figure at full size
Graphical abstract. Yen et al., CC BY-NC-ND

Our read

Populations
Studied:
Cohort study of 1,269 patients with Alzheimer disease, median 112 months
What changed:
Psychiatric diagnoses did not independently predict death from any cause after accounting for dementia severity, demographic factors, and medical conditions
The catch:
Diagnosis codes did not measure the severity of active psychiatric or behavioral symptoms
In the record:
The 18th paper on psychotropic medications with results in people; 20 on record in all.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Among 1,269 patients with specialist-confirmed, clinically diagnosed Alzheimer disease in Taiwan, a retrospective cohort study examined psychiatric diagnoses, recorded medication exposure and long-term survival. Patients received care at a specialist neurology and psychiatry outpatient practice. During a median follow-up of 112 months, 332 patients died.

Psychiatric diagnoses and recorded use of psychiatric medicines were common. Neither independently predicted death from any cause after the researchers accounted for dementia severity, demographic factors and medical conditions. Older age, male sex, kidney failure and cancer were associated with higher mortality. The authors emphasized that these findings did not negate earlier evidence linking active psychiatric and behavioral symptoms or newly started psychiatric medicines with mortality.

Why it matters

For Alzheimer disease, the authors emphasize that assessing survival requires distinguishing active symptoms from formal diagnoses and recorded medication exposure.

Caveats

Diagnosis codes and medication records do not measure the severity of active psychiatric or behavioral symptoms. The findings concern patients receiving specialist outpatient care in Taiwan.

Where the evidence stands

Antidepressants

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 69 independent labs in 33 countries
  • 12 findings against
  • 6 trials, 5 with no results posted
  • Funders: National Institutes of Health and others
  • 11 of 96 findings with company ties

Antipsychotics

Humans: replicated by independent labs. Cells: a single group. Worms or flies and mice: nothing yet.
  • 55 independent labs in 23 countries
  • 13 findings against
  • 5 trials, 2 with no results posted
  • Funders: National Institute on Aging and others
  • 12 of 73 findings with company ties

Comments

Be the first to comment.